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Background: The prevalence of dementia is expected to rapidly increase in the next
decades, warranting innovative solutions improving diagnostics, monitoring and resource
utilization to facilitate smart housing and living in the nursing home. This systematic review
presents a synthesis of research on sensing technology to assess behavioral and
psychological symptoms and to monitor treatment response in people with dementia.
Methods: The literature search included medical peer-reviewed English language
publications indexed in Embase, Medline, Cochrane library and Web of Sciences,
published up to the 5th of April 2019. Keywords included MESH terms and phrases
synonymous with “dementia”, “sensor”, “patient”, “monitoring”, “behavior”, and “therapy”.
Studies applying both cross sectional and prospective designs, either as randomized
controlled trials, cohort studies, and case-control studies were included. The study was
registered in PROSPERO 3rd of May 2019.
Results: A total of 1,337 potential publications were identified in the search, of which 34
were included in this review after the systematic exclusion process. Studies were
classified according to the type of technology used, as (1) wearable sensors, (2) non-
wearable motion sensor technologies, and (3) assistive technologies/smart home
technologies. Half of the studies investigated how temporarily dense data on motion
can be utilized as a proxy for behavior, indicating high validity of using motion data to
monitor behavior such as sleep disturbances, agitation and wandering. Further, up to half
of the studies represented proof of concept, acceptability and/or feasibility testing. Overall,
the technology was regarded as non-intrusive and well accepted.
Conclusions: Targeted clinical application of specific technologies is poised to
revolutionize precision care in dementia as these technologies may be used both by
patients and caregivers, and at a systems level to provide safe and effective care. Toin.org February 2020 | Volume 10 | Article 16991
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Frontiers in Pharmacology | www.frontiershighlight awareness of legal regulations, data risk assessment, and patient and public
involvement, we propose a necessary framework for sustainable ethical innovation in
healthcare technology. The success of this field will depend on interdisciplinary
cooperation and the advance in sustainable ethic innovation.
Systematic Review Registration: PROSPERO, identifier CRD42019134313.Keywords: dementia, sensoring, monitoring, behavior, therapyINTRODUCTION
The global health challenge of dementia is exceptional in size,
cost and impact (Wortmann, 2012). The World Health
Organization estimates that 47 million persons live with
dementia worldwide, a number expected to reach 75 million by
2030 and more than triple by 2045 (World Health Organization,
2017). According to the Alzheimer’s Association, dementia-
related costs range from $157 to $215 billion - higher than
costs associated with cancer or cardiac disease— in the US alone,
with roughly $42,000 to $56,000 spent per individual. These costs
are driven to a significant extent by behavioral and psychological
symptoms of dementia (BPSD) such as psychosis, apathy,
hyperactivity, agitation, sleep disorders or depression (Ballard
and Howard, 2006). This symptomatology may be caused
or exaggerated by a range of conditions, such as hypoglycemia,
pain and general discomfort, or they may arise secondary to
the use of both psychotropic and non-psychotropic medications,
which are known to precipitate a wide range of symptoms
(Lyketsos et al., 2006). The prevalence of polypharmacy
further adds to this clinical challenge (Gulla et al., 2016).
Compounding this, no FDA approved pharmacologic
treatments for BPSD exist and a wide range of psychotropic
medications — including antipsychotics, mood stabilizers,
antidepressants, and cholinesterase inhibitors — are regularly
used to manage the symptoms, despite clear guidelines as to
when and how to use them (Ballard and Corbett, 2010). This has
led to vast variance in clinical practice around pharmacologic
management of BPSD (Livingston et al., 2017). Polypharmacy
and inappropriate prescribing can lead to significant adverse
events, including increased fall risk, higher rates of inpatient care,
loss of independence, and it increase the need for monitoring,
which can significantly raise costs of dementia care, especially in
nursing homes (Winblad et al., 2016).
Thus, there is an urgent need for tools that facilitate diagnoses
that are more precise and a deeper understanding of patterns and
triggers for BPSD (Kang et al., 2010). This includes tools that
generate continuous data on behavior patterns, which may
facilitate earlier detection of temporal events and guide more
precise pharmacotherapy. Finally, there is a need for tools that
can more closely monitor treatment response in dementia across
care settings (Teipel et al., 2018).
A wide array of new technologies may provide solutions,
especially those explicitly designed to support people with
dementia and their formal and informal caregivers (Yang and
Kels, 2017). The evidence around this has also been growing within.org 2research highlighting aspects of active and passive technology
used in dementia (Pillai and Bonner-Jackson, 2015; Martinez-
Alcala et al., 2016; Giggins et al., 2017; Brims and Oliver, 2018),
the impact of safety equipment on wandering in dementia (Lin
et al., 2014; Mangini and Wick, 2017), ethical considerations of
surveillance technology in dementia (Sorell and Draper, 2012),
or the need for real-world evidence-based solutions to conduct
clinical trials (Teipel et al., 2018).
In this review paper, we present a synopsis of existing
research studies in this space, including work on both
commercially available as well as prototype technologies. This
includes diagnostic technologies that utilize active and passive
sensing in connection with smart housing, voice recognition and
motion mapping (Teipel et al., 2018), and prognostic approaches
that may inform clinicians about a range of potential responses,
including alterations in circadian rhythm, changes in gait speed,
falls, and variations in spatial location and reduction in resistance
to care.
Finally, we discuss the potential pitfalls of this technology,
specifically related to issues around ethics, privacy and security of
data (Bantry-White, 2018; Chalghoumi et al., 2019) and the
scalability of these technologies in terms to social living
and activities.METHODS
This systematic review presents a synthesis of previous research
on sensing technology to assess behavioral and psychological
symptoms and to monitor treatment response in people
with dementia.
Literature Search
We initially searched for peer-reviewed English language
publications indexed in the following databases: Embase,
Medline, Cochrane library and Web of Sciences, published up
to the 5thof April 2019. Keywords included MESH terms and
phrases synonymous with “dementia”, “sensor”, “patient”,
“monitoring”, “behavior”, “therapy”. See full search history in
the supplementary material. We assessed papers for eligibility
using the PICO criteria (P: population, I: intervention, C:
comparison and O: outcome), (see Table 1). We included
studies applying both cross-sectional and prospective designs,
including randomized controlled trials, cohort studies, and case-
control studies. Reviews, opinion papers, protocols, and
conference abstracts were excluded from the main search results.February 2020 | Volume 10 | Article 1699
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the manuscripts on title and abstract level to select relevant
studies based on the inclusion and exclusion criteria. Potentially
relevant studies were assessed for eligibility by all coauthors by
evaluating the inclusion and exclusion criteria on the full-
text manuscripts. Reference lists of manuscripts and reviews
were screened to identify additional relevant publications. The
final selection of included publications was by consensus among
all authors. The study was registered in PROSPERO 3rd of
May 2019.RESULTS
The systematic search generated 1,337 potential publications
from Embase (601), Cochrane (77) Medline (275), and Web ofFrontiers in Pharmacology | www.frontiersin.org 3Science (384), of which 161 papers were identified as relevant for
full-text evaluation (Figure 1). Of these, 127 papers were
removed from the following results because they were either
editorial review pieces or opinion articles, or because the studies
involved use of technology but not for the primary goal of
managing BPSD. Eighteen (53%) articles were published in
Europe, 10 (29%) in the United States and 6 (18%) in Oceania.
Of the 34 studies selected, 23 focused on management of BPSD
itself, while 11 studies that utilized sophisticated technological
approaches for studying other factors. For example, one study
(Whelan et al., 2018) assessed communication between caregivers
and nursing home staff, while another utilized technology to assess
ability to perform activities of daily living (ADLs) (Stucki et al.,
2014). While these studies did not meet the original inclusion
criteria, by consensus among the co-authors, we elected to include
the studies since they reflect potentially meaningful applications ofTABLE 1 | Inclusion and exclusion criteria.
Inclusion criteria according to PICO Population People with dementia
Intervention Use of sensor technology
Comparison No use of sensor technology
Outcome Changes in behavioral and psychological symptoms in
dementia/neuropsychiatric symptoms in dementia. Validity
of assessment of neuropsychiatric symptoms in dementia
comparing sensor technology with proxy rated symptoms
Exclusion criteria Studies published before 2009. Reviews, protocols,
opinion, and conference papers. Publications in other
languages than English.FIGURE1 | Flow Chart.February 2020 | Volume 10 | Article 1699
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non-pharmacologic management of BPSD.
For our final review, we assessed the full text from the 34
papers that were identified as relevant and divided studies into
four broad categories, based on the type of technology used:
(1) wearable technology, (2) non-wearable motion sensor
technology, (3) assistive technology/smart home technology,
and (4) other technologies not meeting criteria for the above
three. We identified six papers that utilized more than one type
of technology, and incorporated them into one of the above
sections, based on the primary technology for each study.
Wearable Technologies
We identified seven studies that used wearable technologies —
these included multiple sensor systems (two papers), ankle or
wristbands (three papers), or a combination of both (two
papers). We identified four prospective or retrospective cross-
sectional studies along with two cohort studies and one case-
control study. Study length ranged from 100 sec to 18 months.
We noted that five studies utilized wearable technologies to
primarily detect motion and two papers utilized wearable
technologies that detected variables other than motion (body
posture, stress). The details of the identified studies are
summarized in Table 2.
Non-Wearable Motion Sensor
Technologies
We identified 12 studies that utilized sensor-based motion
detection approaches other than wearables. Only one of theseFrontiers in Pharmacology | www.frontiersin.org 4was a randomized controlled trial, with one cohort study, four
cross-sectional studies, two proof of concept studies, two case
studies, and one longitudinal study. The sample sizes of the
studies ranged vastly — from 1 to 265. This broad range reflects
the heterogeneity of applications of motion sensor technologies
for dementia. Study length ranged from two weeks to three years.
Likewise, in the case of wearable technologies, we identified vast
heterogeneity in study indications and purpose. Identified
studies are summarized in Table 3.
Assistive/Smart Home Technologies
We identified 12 studies that utilized sensor rays placed in the
living environment of study subjects. These were variously
referred to as assistive or smart home technologies, since they
required minimal active engagement by the patient or subject.
The studies identified in this category included only one partial
RCT — this study had 3 sites, but investigators were able to
implement the RCT design at only one site. In addition, we
identified three cross sectional/case-control studies, one cohort
study, two case series and two open feasibility studies. We also
identified three qualitative studies in this category. Study length
ranged from 30 min interviews to 15 months and sample sizes
ranged from four individuals to 65. Details of studies using these
technologies are summarized in Table 4.
Other Technologies;
In addition, we identified three studies, each of which deployed a
unique technological approach that could not be classified into
one of the three categories above. One feasibility study (KhoslaTABLE 2 | Studies utilizing wearable technologies.
Author
Country
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2017 Cohort study 30 1 visit Motor-cognitive
impairment










Gait, iTMT performance, accuracy of
iTMT system in detecting motor
planning errors
iTMTABS, Aggressive Behavior Scale; ADL, Activities of Daily Living; BSN, Body sensor network; CMAI, Cohen-Mansfield Agitation Inventory; GSR, Galvanic Skin Response; iTMT, Instru-
mented trail-making task; MMSE, Mini-Mental-Scale Examination.February 2020 | Volume 10 | Article 1699
Husebo et al. Sensing Technology in People With Dementiaet al., 2017) used a human-like robot to assess social and
emotional responses to nonhuman caregivers. Another study
utilized a suite of apps administered via a tablet device as a
nonpharmacologic intervention for agitation in dementia (Vahia
et al., 2017). We identified one study that utilized a text analysisFrontiers in Pharmacology | www.frontiersin.org 5tool to detect variance and patterns of communication between
patients, staff, and caregivers (Whelan et al., 2018). The details of
the studies are summarized in Table 5.
Finally, during the entire review process, we became
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moved, number of hours with
movement, etc.), agreement with
nursing records; system data
agreement with BPSD measured
by NPI
Integrated circuit (IC) tag monitoring system -
measures temporal and spatial movementsBPSD, Behavioral and Psychological Symptoms of Dementia; CDR, Clinical Dementia Rating scale; DCNN, Deep Convolutional Neural Network; EDA, Electro Dermal Activity; GDS,
Geriatric Depression Scale; HR, Human Resources; IC, Integrated circuit; MMSE, Mini-Mental-State Examination; NPI, Neuropsychiatric Inventory; NPI-NH, Neuropsychiatric Inventory-
Nursing Home version; SF-12, Short-Form Health Survey 12; WSN, Wireless Sensor Network.February 2020 | Volume 10 | Article 1699
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Author
Country
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Scale, Beck Anxiety Scale, Trail B., Beck Depression
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and content are presented in Table 6.DISCUSSION
The goal for this review was to identify and summarize the
extent to which literature on technologies (specifically sensors)
have been used in the assessment and management of
behavioral and psychological symptoms of dementia. As theseFrontiers in Pharmacology | www.frontiersin.org 7technologies become widely available, this role is likely to
expand (Collier et al., 2018). We identified several ways
in which these technologies are being studied. This body
of literature will play a crucial role in helping researchers,
clinicians and municipalities, and industry partners to develop
precision approaches to dementia care. We did note, however,
that even though we in our original search aimed at clinical
intervention studies with control groups, the majority of the
studies found are preliminary with relatively small sample sizes
and small durations. Some studies with much larger sampleTABLE 4 | Continued
Author
Country





2014 Feasibility 11 20 days Focus group healthy,
explorative group AD
ADL Monitoring systemFebruary 2020 | VoluAD, Alzheimer`s Disease; ADL, Activities of Daily Living; AT, Assistive technology; CANE, Camberwill Assessment of Needs for the Elderly; DAS, Daily Activity Scenario; GDS, Geriatric
Depression Scale; HDRS, Hamilton Depression Rating Scale; IADL, Instrumental Activities of Daily Living; MCI, Mild Cognitive Impairment; MMSE, Mini-Mental-State Examination; MoCA,
Montreal Cognitive Assessment; NPI, Neuropsychiatric Inventory; RBMT, Rivermead Behavioral Memory Test; SSCO, Short Sense of Competence questionnaire; WHOQOL,World Health
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specificity, etc.)
Validity of Discursis software in detecting
different types of “trouble-indicating





communication behaviorTABLE 6 | Terminology and content of different devices.
Terms Devices Tasks
Noninvasive body sensor network technology Wearables on wrist, waist, and ankle e.g.
accelerometer
Detect skin constitution; skin temperature; activities;
environmental light and temperature
3D Hybrid motion sensors of body postures Uni- and multi-axial accelerometers Body posture
Unobtrusive sensing technologies with signal processing
of real-world data (or monitoring system (TIHM) using
Internet of Things, IoT)
Passive, wireless infrared motion
sensors, analyzed by machine learning
algorithms
Tracks entrances/exits and walking speeds in the home Track
motion; pressure; central energy consumption
Integrated Circuit tag monitoring system Antennas set up on the ceiling and
related to a software platform
Register signals when patients moved under them
Passive, web-based, non-intrusive, proxy-free, assistive
technology (AT)
Wii (Nintendo); iPads; iPhones;
computers; video cameras; medication
management, and alarms
Support of mobility and leisure; cognitive games; social robots;
reminders or prompters; social applications, detection/
classification of ADL/IADL deficits
Sensor and feedback technology Individually pre-recorded voice reminder Memory support
Information and communication technology (ICT) Imaging and video processing to improve
assessments
Detect functional impairment and be more pragmatic, ecological
and objective to improve prediction of future dementia
Tablet devices as novel non-pharmacologic tools iPads 70 installed applications support challenging patient behavior
Discourse analysis software Automated text-analytic tool Quantify communication behavior by discriminating between
diverse types of trouble and repair signalling behaviorme 10 | Article 1699
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large surveys of participants around technology use. This
dearth in intervention studies suggests that the grounds for
innovation, validation, and clinical transference of technology
in the management of behavioral symptoms are fertile.
Though we classified technologies into three broad
categories, we identified several common underlying themes.
Firstly, almost half of studies across the three categories
represent ways in which temporarily dense data on motion
can be processed and aggregated as proxy for behavior.
Findings from these studies indicate high validity of using
motion data to detect and track behavioral symptoms such
as sleep disturbances, agitation, and wandering (Rowe
et al., 2009; Bankole et al., 2012; Sacco et al., 2012; Yamakawa
et al., 2012; Aloulou et al., 2013; Galambos et al., 2013;
Stucki et al., 2014; Fleiner et al., 2016; Hattink et al., 2016;
Jekel et al., 2016; Lazarou et al., 2016; Merilahti et al.,
2016; Alvarez et al., 2018; Enshaeifar et al., 2018). Continuous
motion monitoring of people with dementia using sensor
technology provides informal caregivers and health care
providers with the ability to more immediately and accurately
diagnose and manage behavioral disturbances and can help
to delay admission to long-term care or inpatient facilities.
In a prodromal population, data from 8 of the studies suggest
that motion data can also be useful in early detection of
mild cognitive impairment and/or mild Alzheimer`s disease
(Sacco et al., 2012; Hsu et al., 2014; Akl et al., 2015; Dodge
et al., 2015; Gochoo et al., 2018; Zhou et al., 2018). While the
majority of identified studies focused on the assessment of
behaviors, we also identified 8 studies that developed
intervention approaches based on sensor data or other
feedback (Rowe et al., 2009; Aloulou et al., 2013; Martin
et al., 2013; Hattink et al., 2016; Vahia et al., 2017; Khosla
et al., 2017; Melander et al., 2018).
In addition, out of 34 studies, we found that 16 studies
represented proof-of-concept, acceptability, and/or feasibility
testing for technologies that are new and have not been used
in the dementia population previously. These studies
demonstrated some usability issues for smart home and
assistive systems, e.g., technological malfunctions and general
user-unfriendliness; however, the technology used was
predominantly non-intrusive and well-accepted (Hattink et al.,
2016; Olsson et al., 2018).
In terms of data privacy and security, we noted that the
majority of our identified articles conclude their discussion by
encouraging stakeholders to respect users’ privacy and
autonomy. Several ask for legal frameworks and regulations to
monitor the rapid development of this promising area
(Yokokawa, 2012; Yang and Kels, 2017; Khan et al., 2018;
Teipel et al., 2018). While we did not specifically identify
clinical studies related to ethics, data privacy and security in
our review, we present a synopsis of this topic, since the eventual
acceptability of new technologies in dementia will be contingent
on the development of transparency and trust around digital
tools. This is highlighted in several opinion papers and review
articles, which discuss ethical considerations in sensingFrontiers in Pharmacology | www.frontiersin.org 8technology for people with dementia or intellectual and
developmental disabilities (Table 7).
Launched inMay 2018, the General Data Protection Regulation
(GDPR) is the novel European Union-wide law on data protection
— a significant step towards more responsible protection of
individuals (Crutzen et al., 2019). While it is recognized that
participation in research is based on affirmative, unambiguous,
voluntary, informed, and specific consent (Mendelson, 2018),
people with advanced dementia or intellectual and
developmental disabilities are not able to give informed consent
or understand the consequences of data acquisition (Friedman and
Rizzolo, 2017; Chalghoumi et al., 2019; Timmers et al., 2019).
Article 6 of the GDPR addresses this issue by including provisions
that protecting persons with dementia and their relatives from
being coerced into providing consent without awareness of how
their data will be used (Cool, 2019; Crutzen et al., 2019). Despite
this regulation, local legislation differs between European countries
(de Lange et al., 2019). In Norway, for, e.g., a family member or
legal advocate may provide or refuse consent based on their
determination around whether the person with dementia would
agree or decline to participate in a given study (Husebo et al.,
2019). In Germany, the inclusion of people with dementia is
limited for only those who may directly benefit from research
results. To further strengthen privacy protections, Article 35 of the
GDPR requires the Data Protection Impact Assessment (DPIA)
(Figure 2) (Donnelly and McDonagh, 2019), which mandates that
only the most relevant personal data is collected (data
minimization), and limits data access to those who are
authorized or given permission by the individual (Yang and
Kels, 2017). Overall, in this review, we did not specifically
include search keywords relating to ethics in sensor technology
but we recognized an engaged discussion in a considerable number
of position papers and reviews around ethical considerations and
especially, the need for data protection, proper transfer and storage
(Holm and Ploug, 2013; Ploug and Holm, 2013).
Agencies that provide funding for research increasingly
require patient and public involvement (PPI) in design,
implementation, and dissemination of health research
(Figure 2) (Melander et al., 2017; Melander et al., 2018). The
goal of PPI is to ensure user-centered design so that persons who
may benefit from it have an opportunity, especially in the early
stages of their disease (Landau and Werner, 2012; Bantry-White,
2018) to understand the purpose of the technology (e.g.
GPS) and to express values, wishes, and concerns to formal
and informal caregivers, We noted that this principle was
incorporated into at least three studies that we reviewed
(Landau and Werner, 2012; Lariviere, 2017; Mangini and
Wick, 2017; Bantry-White, 2018). This approach is also likely
to optimize technology engagement in dementia (Nijhof et al.,
2013; Mehrabian et al., 2014). A related principle, Responsible
Research and Innovation (RRI) (Figure 2), is defined as a
transparent, interactive process by which societal actors and
innovators become mutually responsive to each other (von
Schomberg, 2013). They are encouraged to assume a critical
perspective when evaluating the innovation and marketability of
products (Holthe et al., 2018; Lehoux and Grimard, 2018). ThisFebruary 2020 | Volume 10 | Article 1699
Husebo et al. Sensing Technology in People With Dementiaapproach may serve to promote awareness of technologies and
related issues across both groups of stakeholders (van Haeften-
van Dijk et al., 2015; Wu et al., 2017; Rostill et al., 2018).LIMITATIONS
Our findings and recommendations must be interpreted in the
context of some limitations. During the process, we recognized
that the MESH terms and phrases synonymous with “dementia”,Frontiers in Pharmacology | www.frontiersin.org 9“sensor”, “patient”, “monitoring”, and “behavior”, and “ therapy”
probably did not cover the whole range of interesting topics. For
instance, items such as ethics, activities of daily living (ADL), and
communication, may increase the understanding for and
connection to the clinical aspects of this quickly developing
area. Because of the vast heterogeneity of the literature,
including terminology and definitions of sensing technology, a
meta-analysis that may facilitate aggregated recommendations
was not feasible. We also noted that the majority of the studies
were open-label early-stage studies. Replication of these findingsTABLE 7 | Review and opinion articles on ethical considerations in sensing technology for people with dementia or intellectual and developmental disabilities.





2018 Scope review on
ethics of electronic
monitoring in PWD
a) Autonomy/liberty: Who decides the person`s interests? Identification of past and present wishes for ethical decision
making; liberty by electronic monitoring; b) Privacy: Monitoring may be less intrusive than constant caregiver presence; c)
Dignity: May technology be a stigma in context to a social construct? d) Monitoring formal and informal caregiving may









People show awareness of privacy concerns but not due to the use of technology. Privacy breaches are a major risk in I/






2017 National I/DD survey
on electric video
monitoring
Video monitoring are effective methods to expand community care while being cost effective. However, it should also aim




2010 Opinion paper on in
situ monitoring of
older adults
Monitoring can replace caregiver-patient interaction and social contact but also the opposite in providing increased







ethics on GPS use
for PWD
a) Maintain balance between the needs of PWD for protection and safety and their need for autonomy and privacy; b)
Decision for GPS use together with PWD (informed consent) and family; c) Advance directives or earlier wishes in case of








Participants are positive to home telecare, cognitive stimulation program and devices’ care of emergencies with potential
to improve QoL. Ethical concerns (e.g. way of provision, installation, monitoring) are reported with needs for proper





2013 Scope review on
practice & future
direction
Summarize current use of assistive technology with focus on effectiveness, and potential benefits, and discuss the ethical





2012 Position paper on
telecare, surveillance
and welfare state
Telecare may not be regarded as objectionable extension of a “surveillance state (Orwellian),” but a danger of deepening
the isolation of those who use it. Telecare aims to reduce costs of public social and health care; correlative problem of









This paper discusses clinical, technological, ethical, regulatory, user-centred requirements for collecting continuously RWE
data in RCTs. Data safety, quality, privacy and regulations need to be addressed by sensor technologies, which will





2018 Explorative study on
RTLS in NHs
Interviews with formal caregivers; NH patients and family members, and researchers. Concerns differed between groups




2010 Position paper on
surveillance of
pacing in PWD
Surveillance technologies such as locked doors dehumanise and frighten individuals, whereas motion detectors may





2017 Scope review on
ethics of electronic
monitoring for PWD
To protect and empower PWD, the decision-making capacity of the person has to be evaluated and a multidisciplinary
process (including PWD, relatives and healthcare professionals) have to be conducted before electronic monitoring (GPS,
radiofrequency, cellular triangulation) is used.ICT, Information and Communication Technology; I/DD, Intellectual and developmental disabilities; GPS, Global Positioning System; NH, Nursing Home; PWD, People with Dementia;
QoL, Quality of Life; RCT, Randomized Controlled Trial; RTLS, Real Time Location Systems; RWE, Real World Evidence.February 2020 | Volume 10 | Article 1699
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the standard of care. Our search algorithm also has potential
limitations. We restricted our search to the past decade, since we
anticipate that future sensor-based care models will be built on
contemporary technology. We determined that tools that are
more than a decade old are unlikely to have relevance in
the future.CONCLUSION
Overall, our systematic review demonstrates that sensor
technologies have a broad range of potential applications in
dementia care, ranging from early detection of cognitive
impairment to aid in the management of behavioral and
psychological symptoms in late stage dementia. Targeted
clinical application of specific technologies is poised to
revolutionize precision care in dementia as these technologies
may be used by patients themselves, caregivers, or even applied at
a systems level (e.g., nursing homes) to provide more safe and
effective care. As sensor technology matures in its ability to guide
care in BPSD, it may generate novel ways to capture early
symptomatology (e.g., social isolation), improve specificity for
cognitive testing in-situ and facilitate cost effective research
approaches. A small but rapidly growing body of evidence
around sensors in dementia care is paving the early way for
the field, bringing into focus both the potential and pitfalls of this
approach. Next step in this field may be to investigate the validity
of use not only for care purposes, but also for prognostics as well
as acceptability, feasibility, and responsiveness in clinical trials.
The eventual success of this field will depend on inter-
disciplinary models of research, development by industry
partners, and sustainable ethic innovation in healthcare
technology and smart housing.Frontiers in Pharmacology | www.frontiersin.org 10DATA AVAILABILITY STATEMENT
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